Find the funding your business is owed
GrantHub tracks 1,902+ active grants, tax credits, and funding programs across 21 countries. Filter by your country and industry to uncover government schemes, foundation funding, and corporate grants your business can apply for — verified and updated weekly.
Grants in United States
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on ancillary studies that aim to leverage the resources from the ongoing pare
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
The National Human Genome Research Institute (NHGRI) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for research on proof of concept studies that explore novel strategies for identifyi
Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trials not allowed)
National Institutes of Health
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) consortium to elucidate mech
Infrastructure for Population Dynamics Research Program (iPOP)
National Institutes of Health
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research infrastructure support in order to advance the fiel
Assistive Technology Alternative Financing Program
Administration for Community Living
The purpose of the Assistive Technology (AT) Alternative Financing Program (AFP) is to support programs that provide for the purchase of AT, such as a low-interest loan fund, an interest buy-down program, a revolving loan fund, a loan guarantee, or a
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
Food and Drug Administration
The purpose of this funding opportunity is to examine the utility of an in vitro simulated gastrointestinal (GI) dissolution model for the assessment of in vitro performance of amorphous solid dispersion (ASD) drug products under different clinically
Frequently asked questions
GrantHub is an informational directory. Grant eligibility, amounts, and deadlines are subject to change. Always verify details on the official funding body's website before applying. GrantHub does not guarantee eligibility or funding outcomes.